Clinical Trial Update: Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated a regimen of carboplatin, irinotecan, and radiation therapy followed by docetaxel in patients with newly diagnosed stage III non-small…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)
• Irinotecan (Irinotecan)

Snippet

Sponsor: University of Miami | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED